Search research articles
Contact Us
Filters
Showing results (1-10 of 34) with videos related to
Page
of 4
Sort By:
Expert Opinion on Pharmacotherapy
|
July 29, 2016
Obeticholic acid for the treatment of primary biliary cholangitis
Ahmad H Ali, Keith D Lindor
Clinical Liver Disease
|
May 2, 2019
Novel treatments in primary sclerosing cholangitis
Ahmad H Ali, Keith D Lindor
Expert Review of Gastroenterology & Hepatology
|
November 3, 2015
The management of autoimmunity in patients with cholestatic liver diseases
Ahmad H Ali, Elizabeth J Carey, Keith D Lindor
Gastroenterology & Hepatology
|
September 1, 2018
Primary Sclerosing Cholangitis, Part 2: Cancer Risk, Prevention, and Surveillance
James H Tabibian, Ahmad H Ali, Keith D Lindor
Seminars in Liver Disease
|
December 21, 2016
The Microbiome and Primary Sclerosing Cholangitis
Ahmad H Ali, Elizabeth J Carey, Keith D Lindor
Clinical Gastroenterology and Hepatology : the Official Clinical Practice Journal of the American Gastroenterological Association
|
October 9, 2019
Associations Between Drug Exposure and Outcomes in Patients With Primary Sclerosing Cholangitis and Inflammatory Bowel Disease
Brian M Fung, Ahmad H Ali, James H Tabibian
Lancet (London, England)
|
September 15, 2015
Primary biliary cirrhosis
Elizabeth J Carey, Ahmad H Ali, Keith D Lindor
Annals of Translational Medicine
|
February 24, 2015
Recent advances in the development of farnesoid X receptor agonists
Ahmad H Ali, Elizabeth J Carey, Keith D Lindor
Intractable & Rare Diseases Research
|
February 13, 2015
Current research on the treatment of primary sclerosing cholangitis
Ahmad H Ali, Elizabeth J Carey, Keith D Lindor
Gastroenterology & Hepatology
|
July 12, 2018
Primary Sclerosing Cholangitis, Part 1: Epidemiology, Etiopathogenesis, Clinical Features, and Treatment
James H Tabibian, Ahmad H Ali, Keith D Lindor
Page
of 4
Search research articles
Search
Showing results (1-10 of 34) with videos related to
Sort By:
Page
of 4
Expert Opinion on Pharmacotherapy
|
July 29, 2016
Obeticholic acid for the treatment of primary biliary cholangitis
Ahmad H Ali, Keith D Lindor
Clinical Liver Disease
|
May 2, 2019
Novel treatments in primary sclerosing cholangitis
Ahmad H Ali, Keith D Lindor
Expert Review of Gastroenterology & Hepatology
|
November 3, 2015
The management of autoimmunity in patients with cholestatic liver diseases
Ahmad H Ali, Elizabeth J Carey, Keith D Lindor
Gastroenterology & Hepatology
|
September 1, 2018
Primary Sclerosing Cholangitis, Part 2: Cancer Risk, Prevention, and Surveillance
James H Tabibian, Ahmad H Ali, Keith D Lindor
Seminars in Liver Disease
|
December 21, 2016
The Microbiome and Primary Sclerosing Cholangitis
Ahmad H Ali, Elizabeth J Carey, Keith D Lindor
Clinical Gastroenterology and Hepatology : the Official Clinical Practice Journal of the American Gastroenterological Association
|
October 9, 2019
Associations Between Drug Exposure and Outcomes in Patients With Primary Sclerosing Cholangitis and Inflammatory Bowel Disease
Brian M Fung, Ahmad H Ali, James H Tabibian
Lancet (London, England)
|
September 15, 2015
Primary biliary cirrhosis
Elizabeth J Carey, Ahmad H Ali, Keith D Lindor
Annals of Translational Medicine
|
February 24, 2015
Recent advances in the development of farnesoid X receptor agonists
Ahmad H Ali, Elizabeth J Carey, Keith D Lindor
Intractable & Rare Diseases Research
|
February 13, 2015
Current research on the treatment of primary sclerosing cholangitis
Ahmad H Ali, Elizabeth J Carey, Keith D Lindor
Gastroenterology & Hepatology
|
July 12, 2018
Primary Sclerosing Cholangitis, Part 1: Epidemiology, Etiopathogenesis, Clinical Features, and Treatment
James H Tabibian, Ahmad H Ali, Keith D Lindor
Page
of 4